One-Year Tuberculosis Risk in Rheumatoid Arthritis Patients Starting Their First Tumor Necrosis Factor Inhibitor Therapy from 2008 to 2012 in Taiwan: A Nationwide Population-Based Cohort Study.
Chong-Hong LimChing-Heng LinDer-Yuan ChenYi-Ming ChenWen-Cheng ChaoTsai-Ling LiaoHsin-Hua ChenPublished in: PloS one (2016)
This study showed that the 1-year TB risk in RA patients starting TNFi therapy was significantly higher than that in non-TNFi controls in Taiwan from 2008 to 2012.
Keyphrases
- rheumatoid arthritis patients
- disease activity
- rheumatoid arthritis
- mycobacterium tuberculosis
- end stage renal disease
- ejection fraction
- newly diagnosed
- prognostic factors
- systemic lupus erythematosus
- emergency department
- stem cells
- ankylosing spondylitis
- patient reported outcomes
- mesenchymal stem cells
- pulmonary tuberculosis
- hepatitis c virus
- interstitial lung disease
- patient reported
- smoking cessation